Nachrichten zur Zai Lab Ltd. (ADRs) Aktie

Zai Lab to Announce Second Quarter 2023 Financial Results and Corporate Updates on August 7, 2023

- Company to Host Conference Call and Webcast on August 8, 2023, at 8:00 a.m. ET - Company to Host…

JAMA Oncology Publishes Data from Zai Lab Study Demonstrating Significant Reduction in Disease Progression or Death with ZEJULA (Niraparib) Maintenance Therapy in Broad Population of Advanced Ovarian Cancer Patients

The Phase 3 PRIME study demonstrates that treatment with ZEJULA significantly extends progression-free survival versus placebo and reduces the risk…

Argenx/Zai Lab rise on phase 2 results for autoimmune disorder asset

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Argenx, Zai Lab Shares Rise After Positive Trial Results for Vyvgart Hytrulo

Argenx, Zai Lab Shares Rise After Positive Trial Results for Vyvgart Hytrulo...…

Biggest stock movers today: BridgeBio Pharma, Zai Lab, argenx and more

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zai Lab and argenx Report Positive Topline Data from ADHERE Study of VYVGART Hytrulo in Patients with Chronic Inflammatory Demyelinating Polyneuropathy

SHANGHAI, China and CAMBRIDGE, Mass., July 17, 2023 (GLOBE NEWSWIRE) --  Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688)…

Zai Lab Announces First Patient Treated in Mainland China for the Global Phase 3 FORTITUDE-101 Study of Bemarituzumab in First-Line Gastric Cancer

SHANGHAI, China and CAMBRIDGE, Mass., July 14, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688)…

Zai Lab Promotes Yajing Chen to Finance Chief

Zai Lab Promotes Yajing Chen to Finance Chief...…

Zai Lab names CFO

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Zai Lab Ltd For: Jul 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zai Lab Announces Promotion of Yajing Chen to Chief Financial Officer

SHANGHAI, China and CAMBRIDGE, Mass., July 06, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688)…

Form 8-K Zai Lab Ltd For: Jun 30

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

argenx and Zai Lab Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China

Amsterdam, the Netherlands— June 30, 2023 -- argenx SE (Euronext & Nasdaq: ARGX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX:…

Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China

First-and-only approved FcRn antagonist for gMG patients by NMPA...…

Form 8-K Zai Lab Ltd For: Jun 20

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Chinese biotechs Hutchmed, Zai Lab trade down significantly

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

WUXI BIO Deepens Slide to 17%; Pharmas Crater Over 5%-7%

WUXI BIO (02269.HK) deepened the slide after midday. It stumbled 17% to last at $38.85. Other pharmaceuticals were hard to…

Why Shares of Zai Lab Are Dropping Wednesday

The company released a phase 3 trial regarding a non-small cell lung cancer therapy....…

Form 8-K Zai Lab Ltd For: Jun 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies

Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median…

Zai Lab to Highlight New Data from its Oncology Pipeline at 2023 ASCO Annual Meeting

Three poster presentations to provide updates on Zai Labs oncology programs focused on unresectable solid tumors, ovarian cancer and gastrointestinal…

Zai Lab Announces Participation in June Investor Conferences

SHANGHAI, China and CAMBRIDGE, Mass., May 25, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688)…

Why Shares of Alibaba, PDD, and Zai Lab Are Rising Today

Several Chinese stocks rose today after positive sentiment from Wall Street and recent comments made by President Biden....…

Zai Lab: Q1 Earnings Insights

read more...…

Zai Lab inks license deal with MediLink for potential cancer drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zai Lab Announces Strategic Partnership and Global License Agreement with MediLink Therapeutics for a Next Generation Antibody-Drug Conjugate Program in Oncology

YL212 expands Zai Labs lung cancer franchise and enriches its global oncology pipeline with a potential first-in-class ADC YL212 expands…

Zai Lab to Announce First Quarter 2023 Financial Results and Corporate Updates on May 9, 2023

Company to Host Conference Call and Webcast on May 10, 2023, at 8:00 a.m. ET Company to Host Conference Call…

Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual Meeting

New translational and clinical biomarker data from Zai Labs global oncology program ZL-1211 will be featured in a poster presentation…

Karuna/ Zai Lab succeed in late-stage trial for schizophrenia candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia

Third positive registrational trial met its primary endpoint, with KarXT demonstrating an 8.4-point reduction in PANSS total score compared to…

Does Zai Lab Limited Unsponsored ADR (ZLAB) Have the Potential to Rally 115.25% as Wall Street Analysts Expect?

The consensus price target hints at an 115.3% upside potential for Zai Lab Limited Unsponsored ADR (ZLAB). While empirical research…

Zai Lab GAAP EPS of -$4.63 beats by $0.30, revenue of $215M misses by $1.4M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Zai Lab Ltd For: Mar 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zai Lab Announces Participation in March Investor Conferences

SHANGHAI and CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), today…

Zai Lab to Present Two New Phase 3 Analyses for Niraparib in Ovarian Cancer at the 2023 ESMO Gynaecological Cancers Congress

SHANGHAI, China and CAMBRIDGE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688)…

Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023

Company to Host Conference Call and Webcast on March 2, 2023, at 8:00 a.m. ET Company to Host Conference Call…

Zai Lab Announces Participation in February Investor Conferences

SHANGHAI and CAMBRIDGE, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), today…

Paratek/ Zai Lab antibiotic added for reimbursement in China

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zai Lab Limited Unsponsored ADR (ZLAB) Soars 17.6%: Is Further Upside Left in the Stock?

Zai Lab Limited Unsponsored ADR (ZLAB) witnessed a jump in share price last session on above-average trading volume. The latest…

ADR Shares End Mostly Lower; Zai Lab, HSBC Trade Actively

ADR Shares End Mostly Lower; Zai Lab, HSBC Trade Actively...…

Why Shares of Zai Lab Soared This Week

A strong phase-3 clinical trial boosted investors hopes for the Chinese biotech company....…

Zai Lab, Novocure Shares Rise After Positive Trial Result for Lung-Cancer Treatment

Zai Lab, Novocure Shares Rise After Positive Trial Result for Lung-Cancer Treatment...…

Thinking about buying stock in Novocure, Zai Lab, Kala Pharmaceuticals, Orchard Therapeutics, or CytomX Therapeutics?

NEW YORK, Jan. 5, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVCR, ZLAB, KALA, ORTX, and CTMX. To…

Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint

The LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival...…

Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global Oncology Research and Development

SHANGHAI and CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) a…

Zai Lab Announces Participation in January Investor Conferences

SHANGHAI, China and CAMBRIDGE, Mass., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688),…

Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Phase 3 Study at the ESMO Virtual Plenary

-   Median overall survival (mOS) was numerically longer for patients receiving ZEJULA regardless of biomarker status, at 46.3 months compared…

Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

SHANGHAI and CAMBRIDGE, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a…

Insiderhandel: Vorstand verkauft Aktien von Zai Lab im Wert von 74.163$

Reinhart, Harald - Vorstand - Tag der Transaktion: 2022-11-15...…

Zai Lab GAAP EPS of -$0.17 beats by $1.10, revenue of $57.5M beats by $3.77M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…